2007
DOI: 10.1038/ncpgasthep0902
|View full text |Cite
|
Sign up to set email alerts
|

Hamartomatous polyposis syndromes

Abstract: The hamartomatous polyposis syndromes are a heterogeneous group of disorders that share an autosomal-dominant pattern of inheritance and are characterized by hamartomatous polyps of the gastrointestinal tract. These syndromes include juvenile polyposis syndrome, Peutz-Jeghers syndrome and the PTEN hamartoma tumor syndrome. The frequency and location of the polyps vary considerably among syndromes, as does the affected patient's predisposition to the development of gastrointestinal and other malignancies. Altho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
180
0
10

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 205 publications
(193 citation statements)
references
References 69 publications
3
180
0
10
Order By: Relevance
“…The hamartomatous polyposis conditions include Peutz-Jeghers, juvenile polyposis and Cowden's syndromes [24,25]. Each of these three is extremely rare, occurring in between one in 100,000 and one in 200,000 persons.…”
Section: The Hamartomatous Polyposis and Other Polyposis Syndromes Ofmentioning
confidence: 99%
“…The hamartomatous polyposis conditions include Peutz-Jeghers, juvenile polyposis and Cowden's syndromes [24,25]. Each of these three is extremely rare, occurring in between one in 100,000 and one in 200,000 persons.…”
Section: The Hamartomatous Polyposis and Other Polyposis Syndromes Ofmentioning
confidence: 99%
“…In this Commentary, we focus on nuclear localization of PTEN, and the importance of this in normal physiology and disease. Other nontraditional mechanisms of regulation are discussed or reviewed elsewhere (Pezzolesi et al, 2006;Teresi et al, 2007;Zbuk and Eng, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…The cause of PJS appears to be a germline mutation of the STK11/LKB1 (serine/threonine kinase 11) tumour suppressor gene in most of the cases (70-80%) [2,3]. Its incidence has been estimated to be one in 120000 births [4].…”
Section: Discussionmentioning
confidence: 99%